Single-Blind Study of STAT-205 in Mild COVID-19

NCT04708327 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: STAT-205

Sponsor

Cytocom, Inc.